Followers | 199 |
Posts | 21792 |
Boards Moderated | 2 |
Alias Born | 11/07/2005 |
Tuesday, September 28, 2021 10:43:38 PM
As head strategic advisor, AI Venturetech has been instrumental in guiding TulsaLabs, a division of Appswarm (OTC:SWRM), in building their next generation technology research lab in Tulsa, OK.
Although still in development stage, TulsaLabs has moved forward with its first clients to begin expanding its technological reach into areas such as wearables, AI, and new urban transportation.
1) GTX Corp (OTC:GTXO) is working with TulsaLabs to develop ‘health analytics’ utilizing artificial intelligence (A.I.) to assist in potentially extending human life span.
TulsaLabs will utilize data generated from GTXO wearable devices and sensors to develop cloud-based analytics that will monitor and analyze a user’s health data through long-term dataset development utilizing artificial intelligence.
This platform data will allow users to detect potential trends that can be offset with lifestyle adjustments to prevent the onset of some of the most common metabolic diseases such as diabetes, heart disease, and obesity.
Combined together, GTXO and SWRM look to break into the exciting life extension market as emerging player in the wearable industry.
2) Touchpoint Group (OTCQB: TGHI), together with Tulsalabs, announced plans to develop new urban transportation technologies, such as drone transportation all the way to personalized jetpacks.
Through TGHI recent acquisition of the World Championship Air Race (WCAR) both parties will explore leveraging technological in green power and advanced aerial mobility, including electric powered aircraft, EVTOL (vertical takeoff and landing), and personalized Jetpacks.
https://aiventuretech.com/tulsalabs-creates-partnerships-with-touchpoint-tghi-and-gtx-corp-gtxo/
Have a crypto token or stock you are following?
Share it in Crypto Tokens and Blockchain Stocks Group
https://investorshub.advfn.com/boards/board.aspx?board_id=21852
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM